NCT01309451

Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema

A Single Masked, Randomized Controlled Study to Assess Efficacy of Ozurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Diabetic Macular Edema

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Maturi, Raj K., M.D., P.C. · Individual
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators hypothesize that a combination treatment with Avastin and Ozurdex will result in a more rapid improvement of visual acuity compared to the use of Avastin alone.

Conditions

• Diabetic Macular Edema

Interventions

Type	Name	Description
DRUG	Bevacizumab	intravitreal, 1.25mg., monthly
DRUG	dexamethasone intravitreal implant	0.7mg, intravitreal every 4 months

Timeline

• Start date: 2011-03-01
• Primary completion: 2013-04-01
• Completion: 2013-04-01
• First posted: 2011-03-07
• Last updated: 2014-10-29
• Results posted: 2014-10-29

Locations

1 site across 1 country: United States